Enlife raises Rs 6 crore for AI blood test for Alzheimer's

The Economic Times reports that Bengaluru-based Enlife Research raised Rs 6 crore from Piper Serica to develop an AI-powered blood-test platform for Alzheimer's detection. The startup aims to replace expensive and invasive scans with India-specific biomarker analysis and says its platform could eventually detect disease much earlier from a single blood draw. The funding will support validation, R&D hiring, and moving its first assay toward clinical-grade testing.

Key details: Enlife raised Rs 6 crore led by Piper Serica, The company is building an AI-powered blood-test platform for Alzheimer's detection, The funds will support biomarker validation and clinical-grade assay development.

Why it matters: Healthcare AI funding is moving into India-specific diagnostics, where local datasets and affordability can matter as much as model performance.